HAE Haemonetics Corp

Haemonetics Corp is a health care company. It provides products enabling the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

$51.92  -3.39 (-6.13%)
As of 11/26/2021 13:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  02/21/2001
Outstanding shares:  51,105,232
Average volume:  519,676
Market cap:   $2,826,630,382
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    405024100
ISIN:        US4050241003
Sedol:      2401195
Valuation   (See tab for details)
PE ratio:   84.93
PB ratio:   3.80
PS ratio:   3.03
Return on equity:   4.47%
Net income %:   3.35%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy